Literature DB >> 10807575

Influenza B virus in seals.

A D Osterhaus1, G F Rimmelzwaan, B E Martina, T M Bestebroer, R A Fouchier.   

Abstract

Influenza B virus is a human pathogen whose origin and possible reservoir in nature are not known. An influenza B virus was isolated from a naturally infected harbor seal (Phoca vitulina) and was found to be infectious to seal kidney cells in vitro. Sequence analyses and serology indicated that influenza virus B/Seal/Netherlands/1/99 is closely related to strains that circulated in humans 4 to 5 years earlier. Retrospective analyses of sera collected from 971 seals showed a prevalence of antibodies to influenza B virus in 2% of the animals after 1995 and in none before 1995. This animal reservoir, harboring influenza B viruses that have circulated in the past, may pose a direct threat to humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807575     DOI: 10.1126/science.288.5468.1051

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  125 in total

1.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010.

Authors:  Yi Tan; Wenda Guan; Tommy Tsan-Yuk Lam; Sihua Pan; Shiguan Wu; Yangqing Zhan; Cecile Viboud; Edward C Holmes; Zifeng Yang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 3.  Influenza seasonality: underlying causes and modeling theories.

Authors:  Eric Lofgren; N H Fefferman; Y N Naumov; J Gorski; E N Naumova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.

Authors:  Netanel Tzarum; Robert P de Vries; Wenjie Peng; Andrew J Thompson; Kim M Bouwman; Ryan McBride; Wenli Yu; Xueyong Zhu; Monique H Verheije; James C Paulson; Ian A Wilson
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

5.  Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan.

Authors:  Naoko Nakagawa; Natsumi Higashi; Toshimasa Nakagawa
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

Review 6.  Influenza.

Authors:  John H Beigel
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

Review 7.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

8.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

Review 9.  Broadly neutralizing antibodies against influenza viruses.

Authors:  Nick S Laursen; Ian A Wilson
Journal:  Antiviral Res       Date:  2013-04-09       Impact factor: 5.970

10.  Influenza B virus victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season.

Authors:  Naoko Nakagawa; Ritsuko Kubota; Akiko Maeda; Yoshinobu Okuno
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.